EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An ultrapotent human antibody neutralizes all maturation states of Zika virus

Bo Shu, Thiam-Seng Ng iD, Xin-Ni Lim iD, Shuijun Zhang, Victor A Kostyuchenko iD, Guntur Fibriansah iD, Benjamin D McElvany, Valerie Shyn-Yun Chew iD, Aravinda M de Silva iD, Sean A Diehl iD, Shee-Mei Lok iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2502522122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Bo Shu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore. Hauptthemen laut MEDLINE: Zika Virus, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PMO | National Research Foundation Singapore (NRF), HHS | NIH | NCI | CCR | Basic Research Laboratory (BRL), MOH | Ministry of Health Office for Healthcare Transformation (MOHT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zika virus (ZIKV), a flavivirus, causes a range of clinical complications including microcephaly in human fetuses. Currently, there is no treatment or vaccine. Different maturation states (mature and immature forms) of flavivirus particles have been observed to be released from infected cells and are infectious. To understand how an ultrapotent human antibody (HMAb) A9E can neutralize these Zika particles, we determined the cryoEM structures of the A9E Fab fragment complexed with mature (mZIKV) and immature (immZIKV) ZIKV to 2.8Å and 7.5Å, respectively. A9E binds to an epitope spanning Domain I (EDI), EDIII, and their linker in an E protein protomer in both immZIKV and mZIKV particles. A9E generally inhibited prior to or during virus attachment to cells, via virus aggregation, distortion of virus particles and inhibition of receptor binding. ImmZIKV is particularly sensitive to structural distortion by Fab A9E. The primary mode of infection used by ImmZIKV is via antibody-dependent enhancement of infection (ADE)—the formation of virus complex with nonneutralizing or subneutralizing concentrations of antibodies, that leads to enhanced infection of Fcγ positive myeloid cells. IgG A9E, by itself displays poor ADE activity. When IgG LALA mutant or Fab A9E is added to other enhancing antibody (DV62.5):virus complexes, they can strongly reduce the overall ADE activity. This is likely due to their ability to distort virus particle structure, suggesting that HMAb A9E could be a potential prophylactic and therapeutic candidate against all maturation states of ZIKV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusAntibodies, NeutralizingAntibodies, ViralHumansImmunoglobulin Fab FragmentsZika Virus InfectionCryoelectron MicroscopyEpitopesAnimalsVirionViral Envelope Proteins

Stichwörter der Autor:innen

ZikaantibodycryoEMdengueflavivirus

Substanzen

Antibodies, NeutralizingAntibodies, ViralImmunoglobulin Fab FragmentsEpitopesViral Envelope Proteins

Autor:innen und Institutionen

  • Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
  • Department of Biological Sciences, National University of Singapore, Singapore 117557, Singapore.
  • Department of Microbiology and Molecular Genetics, The University of Vermont, Burlington, VT 05405.
  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7292.

ORCID-Profile: Thiam-Seng Ng, Xin-Ni Lim, Victor A Kostyuchenko, Guntur Fibriansah, Valerie Shyn-Yun Chew, Aravinda M de Silva, Sean A Diehl, Shee-Mei Lok

Förderung

  • PMO | National Research Foundation Singapore (NRF)
  • HHS | NIH | NCI | CCR | Basic Research Laboratory (BRL)
  • MOH | Ministry of Health Office for Healthcare Transformation (MOHT)
  • NIAID NIH HHS
  • Foundation for the NIH (FNIH)
  • NIGMS NIH HHS
  • Ministry of Education - Singapore (MOE)
  • Centers for Disease Control and Prevention Foundation (CDCF)

Zitieren

APA

Shu, B., Ng, T. S., Lim, X. N., Zhang, S., Kostyuchenko, V. A., Fibriansah, G., McElvany, B. D., Chew, V. S., de Silva, A. M., Diehl, S. A., & Lok, S. M. (2025). An ultrapotent human antibody neutralizes all maturation states of Zika virus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2502522122

Vancouver

Shu B, Ng TS, Lim XN, Zhang S, Kostyuchenko VA, Fibriansah G, et al. An ultrapotent human antibody neutralizes all maturation states of Zika virus. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2502522122

BibTeX
@article{Shu2025,
  author = {Shu, Bo and Ng, Thiam-Seng and Lim, Xin-Ni and Zhang, Shuijun and Kostyuchenko, Victor A and Fibriansah, Guntur and McElvany, Benjamin D and Chew, Valerie Shyn-Yun and de Silva, Aravinda M and Diehl, Sean A and Lok, Shee-Mei},
  title = {An ultrapotent human antibody neutralizes all maturation states of Zika virus},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2502522122}
}
Kostenlos starten →